Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (7): 441-442.
Previous Articles Next Articles
GUAN Songmei, FANG Chao*
Received:2018-08-08
Revised:2018-08-08
Online:2018-07-20
Published:2018-08-08
CLC Number:
GUAN Songmei, FANG Chao. One Case of Hypoglycemia Induced by Alogliptin Combined with Metformin[J]. Chinese Journal of Pharmacovigilance, 2018, 15(7): 441-442.
| [1] 母义明,纪立农,宁光,等.二甲双胍临床应用专家共识[J].中国糖尿病杂志,2016,24(10):871-884. [2] Jun Sung Moon, Udayakumar Karunakaran, Sunma Elumalai,et al. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells[J].Journal of Diabetes and Its Complications,2017,1(31)21-30. [3] 史洪波,蔡强.37例二甲双胍致不良反应报告分析[J].中国药物警戒,2013,9(10):563-566. [4] 纪立农. dpp-4抑制剂-基础与临床进展[M].1版.北京:人民卫生出版社2015:172-182. [5] Beatta T,Corsini A.Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences[J]. Drugs,2007,71(11):1441-1467. [6] Pratley R E, McCall T, Fleck P R, et al. Alogliptin use in elderly people: a pooled analysis from phase 2 and 3 studies[J]. J Am Geriatr Soc, 2009 ,57(11):2011-2019. [7] 汤仲明. 2013年上半年美国FDA批准药物简介[J].国际药学研究杂志,2013,40(4):501-509. [8] 王瑜,胡明,占美,等.阿格列汀治疗2型糖尿病的系统评价[J].中国医院药学杂志,2014,34(23):2014-2022. [9] Seino Y, Fujita T, Hiroi S,et al.Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a radomized, double-blind,placebo-controlled trial with an openlabel, long-term extension study[J]. Diabetes Obes Metab, 2012, 14(10):927-936. [10] 陈名道. 胰岛β细胞的“糖毒性”、“脂毒性”与“糖脂毒性”[J].中华内分泌代谢杂志,2009,25(1):5-8. [11] 杨华,魏晶,王嘉仡,等.药物不良反应/事件报告评价方法研究[J].中国药物警戒,2009,6(10):581-587. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
